Integrating Clinical Studies in Health Care Delivery: Post-Market Evidence Generation (11.14.23)

How can FDA and other stakeholders better facilitate and support post-market pragmatic evidence generation studies - studies that answer clinically meaningful questions and address gaps in clinical evidence that directly impact how care is managed in the United States?